| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d140005e1d6d64c0faf46b47397e5f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate |
2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1288878cc7e329aeffa431b6b4975531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7451f8754fd509912839ea82682daa4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6821f6a155324877e7b2c811f0d203d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb10475a6dcce3ac8d7bdcf77b9553ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_171c69e37cc599ed4707ade8f43757d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f274af34998a48be57ec73cac8ba181b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2629687a6d3633f9588fb4f3f5b70f13 |
| publicationDate |
2010-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2780482-A1 |
| titleOfInvention |
Hdl particles for delivery of nucleic acids |
| abstract |
Disclosed are high density lipoprotein-nucleic acid particles, wherein the particles include (a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region, wherein the positively-charged region of the polypeptide associates with the nucleic acid component. Also disclosed are pharmaceutical compositions that include a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region. Methods that concern the particles and pharmaceutical compositions of the present invention are also set forth, as well as kits. |
| priorityDate |
2008-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |